Methyl 2-aminoisonicotinate hydrochloride

Catalog No.: 
ACLPYQ331
CAS No.: 
1210824-89-7
Molecular Formula: 
C7H9ClN2O2
Molecular Weight: 
188.61
Methyl 2-aminoisonicotinate hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$286.00InquiryInquiry
1g95%$718.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-aminoisonicotinate hydrochloride
IUPAC Namemethyl 2-aminoisonicotinate hydrochloride
MDL No.MFCD24849668
Molecular FormulaC7H9ClN2O2
Molecular Weight188.61
SMILESO=C(OC)C1=CC=NC(N)=C1.[H]Cl
InChI KeyFBOGJLMANGURMD-UHFFFAOYSA-N
Synonymmethyl 2-aminoisonicotinate hydrochloride(WS204501);Methyl 2-aminoisonicotinate hydrochloride
CAS No.1210824-89-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACLPYQ331 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACQLNG451 route compound structure diagram
    ACQLNG45113362-28-2In Stock
  4. Then
  5. ACLPYQ331 route product structure diagram
    ACLPYQ3311210824-89-7
Inquiry

2. ACLPYQ331 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWICD431 route compound structure diagram
    ACWICD43158481-11-1In Stock
  2. Then
  3. ACLPYQ331 route product structure diagram
    ACLPYQ3311210824-89-7
Inquiry

3. ACLPYQ331 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRYEF307 route compound structure diagram
    ACRYEF30754221-95-3In Stock
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  4. Then
  5. ACLPYQ331 route product structure diagram
    ACLPYQ3311210824-89-7
Inquiry

Comments (0)